Atorvia Health Technologies
Mississauga
About Atorvia Health Technologies
Atorvia is advancing a pipeline of engineered protein-based therapeutics to prevent cell death and organ failure. The company is developing targeted, protein-based precision therapies to prevent cell death with applications in kidney disease, cardiovascular diseases, neurodegenerative disorders, and certain cancers,
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $55.6K
- Funding stage: Seed
- Last round: Pre-Seed (Mar 2025)
- Website: atorvia.co
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/atorvia-health-technologies-6171 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.